To evaluate the effects of NRF2 polymorphism on patient characteristics (gender, age, ethnicity, smoking and alcohol status), stratification analyses of Nrf2 polymorphisms and CHB, LC, and HCC risk were performed. Here, NFE2L2 is linked to hepatocellular carcinoma.